MedPath

Cristiana Sessa

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:2

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor

Phase 1
Completed
Conditions
Breast Cancer
NSCLC
Endometrial Cancer
Ovary Cancer
Small Cell Lung Cancer (SCLC)
Head and Neck (HNSCC)
Interventions
First Posted Date
2014-02-24
Last Posted Date
2019-05-21
Lead Sponsor
Cristiana Sessa
Target Recruit Count
17
Registration Number
NCT02069158
Locations
🇨🇭

Oncology Institute of Southern Switzerland (IOSI), Bellinzona, TI, Switzerland

Study of Inotuzumab Ozogamicin + Temsirolimus in Patients With Relapsed or Refractory CD22+ B-cell NHLymphoma

Phase 1
Completed
Conditions
B-cell Lymphoma Refractory
Interventions
First Posted Date
2012-02-20
Last Posted Date
2016-06-07
Lead Sponsor
Cristiana Sessa
Target Recruit Count
25
Registration Number
NCT01535989
Locations
🇨🇭

Oncology Institute of Southern Switzerland, Bellinzona, Ticino, Switzerland

🇨🇭

InselSpital, Universitätsspital Bern, Bern, Switzerland

🇨🇭

Kantonsspital St.Gallen, San Gallen, Switzerland

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.